From the Focused Ultrasound Surgery Foundation & Fibroid ReliefA new research center for MR-guided focused ultrasound ablation at the University of Virginia is aiming to become a leader in translational and clinical research for emerging interventional procedures.
A new research center for MR-guided focused ultrasound ablation at the University of Virginia is aiming to become a leader in translational and clinical research for emerging interventional procedures.
"The University is proud to be a partner in helping to turn a ‘big idea' into a world-class facility," said Dr. Tim Garson, provost at the University of Virginia, speaking before dedication ceremonies Sept 14. "This will become the leading center for translational research, education, and patient care in the new and rapidly evolving field of MR-guided focused ultrasound."
Focused ultrasound uses MRI guidance to direct multichannel ultrahigh frequency ultrasound to ablate tumors and treat other conditions as an alternative to open surgery or radiation therapy.
The UVA Center will initially offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. In the future, it will also host clinical trials on uterine fibroids and fertility; Parkinson's disease and epilepsy; liver, brain, breast, and prostate tumors; and pain from bony metastasis.
Together, the state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare, which manufactures ultrasound and MRI systems, and InSightec, an ultrasound equipment maker.
The center is designed to encourage collaboration between scientists and physicians in biomedical engineering, neurosurgery, surgery, radiology, cardiology, radiation oncology, neurology, urology, and gynecology. Potential applications include:
"The mission of the foundation is to develop new applications and to accelerate the worldwide adoption of focused ultrasound," said Dr. Neal Kassell, UVA professor of neurosurgery. "By creating a center of excellence we can make this happen sooner-and thereby reduce the death, disability, and suffering of untold numbers of patients."
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.